Moderna, CureVac and Ocugen offer updates on COVID vaccines, while China cracks down on critics of government’s pandemic response
admin A flurry of announcements relating to COVID vaccines dominated headlines on the pandemic on Monday,…
Read MoreBiopharmaceuticals
Pfizer and BioNTech updated booster shows strong results against new omicron sublineages in fresh analysis of data
A fresh analysis of data on the immune response generated by the bivalent COVID-19 booster…
Read MoreAstraZeneca lifts guidance after forecast-beating profit and sales
AstraZeneca PLC on Thursday lifted its guidance for the full year after reporting a swing…
Read MorePfizer-BioNTech bivalent booster shows higher immune response, but new COVID cases climb back above 40,000 a day
First the good news: Pfizer Inc. and Germany-based partner BioNTech SE said updated trial data…
Read MoreShort sellers hit back at Cassava lawsuit against them: ‘We stand behind everything we wrote’
The defendants in a defamation lawsuit brought by Cassava Sciences have hit back at the…
Read MoreAstraZeneca says advanced trial of breast-cancer drug Capivasertib meets primary endpoints
AstraZeneca PLC said Wednesday that Capivasertib plus Faslodex significantly improved progression-free survival when compared with…
Read MorePfizer sets new prices for its COVID-19 vaccines. The cost? $110 to $130 per dose
Pfizer Inc. PFE, +3.06% said Thursday that it plans to sell the COVID-19 shot it…
Read MorePfizer sets new prices for its COVID-19 vaccines. The cost? $110 to $130 per dose
Pfizer Inc. PFE, +4.67% said Thursday that it plans to sell the COVID-19 shot it…
Read MoreFresh data supports updated boosters targeting omicron subvariants, raising hopes more Americans will get the shot
A flurry of announcements Thursday on COVID vaccines and boosters offered further evidence and support…
Read MoreFresh data supports updated boosters targeting omicron subvariants, raising hopes more Americans will get the shot
A flurry of announcements Thursday on COVID vaccines and boosters offered further evidence and support…
Read More